The Secretary of the Army Dan Driscoll flies in a UH-60 Blackhawk at Fort Irwin March 13, 2025. Driscoll and GEN George attended Project Convergence Capstone 5, which showcased Next Generation Command ...

Michael Block is a 14 time GLAM Award nominated writer, producer, and host of the podcast Block Talk. Throughout his time in the entertainment industry, he has worked on and off Broadway as a stage ...

Prime Video is one of those streamers that we're lucky to get one decent option from each month, but in December we're getting one of its best. Season 2 of the post-apocalyptic drama-comedy Fallout is ...

Some Amazon Prime users may see an early holiday gift roll in thanks to a settlement with the Federal Trade Commission (FTC). The settlement occurred after the FTC alleged that Amazon tricked millions ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (NASDAQ: RXRX) experienced an 11% increase in stock price on Wednesday after JP Morgan raised its rating, noting the promising potential of its MEK inhibitor program. However ...

Recursion Pharmaceuticals, Inc. (RXRX) recently received a notable upgrade from JP Morgan analyst Eric Joseph, who shifted his rating to “Overweight” on December 17, 2025. This upgrade comes as the ...

Prime Video has announced the lineup of movies and TV shows coming to the service in January. The Prime Video January 2026 lineup includes new Amazon original movies, TV shows, and specials. Based on ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...